Cargando…

Pamidronate therapy for hypercalcemia of childhood malignancy

Detalles Bibliográficos
Autores principales:	Sng, Andrew, Loke, Kah Yin, Lim, Yvonne, Ho, Cindy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428516/ http://dx.doi.org/10.1186/1687-9856-2015-S1-P56

Ejemplares similares

An infant with Cushing syndrome
por: Sng, Andrew, et al.
Publicado: (2015)

Pamidronate Rescue Therapy for Hypercalcemia in a Child With Williams Syndrome
por: Sanjad, Sami A., et al.
Publicado: (2018)

Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: a case report
por: Soheilipour, Fahimeh, et al.
Publicado: (2009)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
por: Marco, A, et al.
Publicado: (2008)

PReS-FINAL-2229: Pamidronate in CRMO - a small case series
por: Schuller, M, et al.
Publicado: (2013)

Pamidronate treatment in resistant cases of CRMO – our small case series
por: Vrtíková, Eva, et al.
Publicado: (2014)

Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
por: Loke, Kah-Yin, et al.
Publicado: (2016)

Chronic Recurrent Multifocal Osteomyelitis (CRMO): four cases treated with aminobisphosphonate (pamidronate)
por: Teruzzi, B, et al.
Publicado: (2008)

Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report
por: Mahmoud, Sara, et al.
Publicado: (2018)

Hypercalcemia during renal replacement therapy after liver transplantation
por: Matsumi, J, et al.
Publicado: (2011)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

Height and weight development following cyclical intravenous pamidronate in children and adolescents with chronic recurrent multifocal osteomyelitis (CRMO)
por: Miettunen, PM, et al.
Publicado: (2008)

Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report
por: Martinelli, Stefano, et al.
Publicado: (2022)

Choosing the right treatment for patients with a severe course of chronic non-bacterial osteomyelitis (CNO) - pamidronate or TNF-α blockade?
por: Morbach, H, et al.
Publicado: (2015)

Treatment of the low bone mineral density with intravenous pamidronate in pediatric patients: review of a protocol of a single-day infusion twice a year
por: Ricart, S, et al.
Publicado: (2008)

PReS-FINAL-2275: Improvement of calcinosis cutis with intravenous pamidronate in a 2-year-old girl with progressive widespread skin calcification of unknown origin
por: Mrusek, S, et al.
Publicado: (2013)

Neonatal Hypercalcemia Secondary to Subcutaneous Fat Necrosis Successfully Treated with Pamidronate: A Case Series and Literature Review
por: Samedi, Veronica Mugarab, et al.
Publicado: (2014)

Treatment of osteogenesis imperfecta with intravenous pamidronate in pediatric patients: comparison between a single-day infusion twice a year protocol with other regimens described in the literature
por: Ricart, S, et al.
Publicado: (2008)

Therapy with pamidronate in children with osteogenesis imperfecta
por: Marginean, Otilia, et al.
Publicado: (2017)

Succesful treatment of diffuse sclerosing osteomyelitis of the mandible/mandibular chronic non-bacterial osteitis with intravenous pamidronate: resolution of pain and radiographic bone inflammation with improved cosmetic appearance - a case study
por: Miettunen, Paivi, et al.
Publicado: (2014)

Hypercalcemia of Malignancy in Thymic Carcinoma: Evolving Mechanisms of Hypercalcemia and Targeted Therapies
por: Cheng, Cheng, et al.
Publicado: (2017)

Hypercalcemia of Malignancy
por: Malangone, Steve, et al.
Publicado: (2015)

Hypercalcemia of Malignancy
por: Feldenzer, Kaitlin L., et al.
Publicado: (2018)

Genetic Testing Confirmed the Early Diagnosis of X-Linked Hypophosphatemic Rickets in a 7-Month-Old Infant
por: Poon, Kok Siong, et al.
Publicado: (2015)

Intravenous Pamidronate for Refractory Lymphedema
por: Beigi, A A, et al.
Publicado: (2011)

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
por: Purohit, O. P., et al.
Publicado: (1995)

Short-term Efficacy of Monthly Pamidronate Infusion in Patients with Osteogenesis Imperfecta
por: Choi, Jin-Ho, et al.
Publicado: (2007)

Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Lim, Mie Jin, et al.
Publicado: (2010)

Pamidronate Disodium for Palliative Therapy of Feline Bone-Invasive Tumors
por: Wypij, Jackie M., et al.
Publicado: (2014)

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
por: Lim, Se Won, et al.
Publicado: (2016)

The Neurological Safety of Epidural Pamidronate in Rats
por: Lee, Pyung Bok, et al.
Publicado: (2010)

Intravenous pamidronate for refractory rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2012)

Hypercalcemia of Malignancy and Colorectal Cancer
por: Galindo, Rodolfo J., et al.
Publicado: (2016)

Hypercalcemia of malignancy treated with cinacalcet
por: Asonitis, Nikolaos, et al.
Publicado: (2017)

Endocrine complications in survivors of childhood medulloblastoma
por: Yuet-ling, Joanna Tung, et al.
Publicado: (2015)

PA01.76. Single drug therapy in childhood Apasmara (Epilepsy)
por: Musale, Shweta
Publicado: (2012)

Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
por: Choi, Yunha, et al.
Publicado: (2022)

Recurrent meningoencephalitis and hyponatremia in childhood neurosarcoidosis
por: Isgro, Josephine, et al.
Publicado: (2012)

Pamidronate “zebra lines”: A treatment timeline
por: Loizidou, Avgi, et al.
Publicado: (2017)

Pamidronate Treatment of Osteonecrosis of the Hip in Young Male
por: Lo Gullo, A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1udvbicijqv8hitsgfkqgfqnfj